Skip to main content
SURG
NASDAQ Technology

SurgePays 10-Q Flags Going Concern Doubt and Nasdaq Delisting Risk

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Negative
Importance info
9
Price
$0.24
Mkt Cap
$6.157M
52W Low
$0.202
52W High
$3.14
52W Position info
19% above low
Off High info
92% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

SURG sits 19% above its 52-week low of $0.202.

Summary

SurgePays' 10-Q reveals going concern doubt, Nasdaq delisting risk, and heavy reliance on convertible debt financing, despite a headline Q2 profit driven by a one-time AT&T settlement gain.


Key Events · Earnings and Guidance · SURG

  • Going Concern Doubt

    Management states substantial doubt about the Company's ability to continue as a going concern within one year, citing a $21.3 million working capital deficit and only $1.95 million in unrestricted cash.

  • Nasdaq Delisting Risk

    Company received notices for failing the $35 million minimum market value and $1.00 minimum bid price requirements, with compliance deadlines of September 14, 2026 and September 21, 2026.

  • Derivative Liabilities

    Recognized $1.1 million in derivative liabilities from convertible note features, including $1.17 million in derivative expense and a $0.29 million fair value gain.

  • Subsequent Financing

    After quarter-end, issued $1.27 million in new convertible notes, converted $1.59 million of debt into 7.2 million shares, and sold 17.3 million shares via ATM for $5.85 million gross proceeds.


Analysis · SURG · Technology

The quarterly report reveals that management has substantial doubt about SurgePays' ability to continue as a going concern, with only $1.95 million in unrestricted cash against a $21.3 million working capital deficit. Adding to the pressure, the company faces Nasdaq delisting for failing both the minimum market value and minimum bid price requirements, with compliance deadlines in September 2026. These disclosures, combined with the recent AT&T settlement gain that masked an underlying operating loss, fundamentally alter the risk profile for shareholders.

At the time of this filing, SURG was trading at $0.24 on NASDAQ in the Technology sector, with a market capitalization of approximately $6.2M. The 52-week trading range was $0.20 to $3.14. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SURG - Latest Insights

SURG
Aug 14, 2026, 7:45 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.4143
Real-time Price: $0.245 info
Change: -$0.1693 (-41%) info
Market Cap: $6.157M info
SURG
Aug 06, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.4003
Real-time Price: $0.245 info
Change: -$0.1553 (-39%) info
Market Cap: $6.157M info
SURG
Jul 29, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.230
Real-time Price: $0.245 info
Change: +$0.015 (+7%) info
Market Cap: $6.157M info
SURG
Jul 01, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.6199
Real-time Price: $0.245 info
Change: -$0.3749 (-60%) info
Market Cap: $6.157M info
SURG
Jul 01, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4149
Real-time Price: $0.245 info
Change: -$0.1699 (-41%) info
Market Cap: $6.157M info